{
  "slug": "sun-pharmaceutical-industries",
  "name": "sun-pharmaceutical-industries",
  "description": "Sun Pharma is India’s No. 1 pharmaceutical company and a leading global player in specialty medicines. With over 40 manufacturing facilities and a diverse portfolio, we deliver high-quality medicines across 100 countries. Driven by a commitment to innovation, we continuously strive to enhance access to medicines and improve patient care, creating better health outcomes for millions around the world.",
  "url": "https://optimly.ai/brand/sun-pharmaceutical-industries",
  "websiteUrl": "https://sunpharma.com/",
  "logoUrl": "https://logo.clearbit.com/sunpharma.com",
  "baiScore": 59.9,
  "bai_tier_status": "active",
  "bai_score_status": "active",
  "archetype": null,
  "archetype_status": "active",
  "category": "Pharmaceutical Companies",
  "categorySlug": null,
  "keyFacts": [],
  "aiReadiness": [],
  "competitors": [],
  "competitorsProse": null,
  "inboundCompetitors": [],
  "aiAlternatives": [],
  "parentBrand": null,
  "subBrands": [],
  "updatedAt": "2026-09-11T16:02:00.251Z",
  "verifiedVitals": {
    "website": "https://sunpharma.com",
    "category": "pharmaceutical company",
    "what_it_does": "manufactures and delivers high-quality medicines across 100 countries, focusing on innovation to enhance access to medicines and improve patient care",
    "primary_audience": "patients and healthcare providers globally",
    "core_product": "A diverse portfolio of medicines, including specialty medicines for Neuropsychiatry, Cardiovascular Diseases, Gastroenterology, Pain and Surgery, and Ophthalmology. Specific products mentioned include semaglutide injection (Noveltreat and Sematrinity) and ILUMYA® (tildrakizumab-asmn)."
  },
  "intentTags": null,
  "businessProfileClaims": [],
  "timestamp": 1789917646949
}